spironolactone has been researched along with Aqueductal Stenosis in 3 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Excerpt | Relevance | Reference |
---|---|---|
"In obstructive hydrocephalus and failure of conservative therapy of its overt form, the only method of treatment is surgical intervention aimed at draining the cerebrospinal fluid from the cerebrospinal fluid spaces into the right atrium or the peritoneal cavity with the help of implanted shunts." | 1.27 | [Selection of a method of treating the hydrocephalic syndrome in children]. ( Simernitskiĭ, BP, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Simernitskiĭ, BP | 1 |
Gueli, U | 1 |
Lato, M | 1 |
Cagini, P | 1 |
Black, JA | 1 |
Challacombe, DN | 1 |
Ockenden, BG | 1 |
3 other studies available for spironolactone and Aqueductal Stenosis
Article | Year |
---|---|
[Selection of a method of treating the hydrocephalic syndrome in children].
Topics: Acetazolamide; Adrenocorticotropic Hormone; Cerebrospinal Fluid Shunts; Combined Modality Therapy; D | 1984 |
[Prospects of medical treatment in communicating congenital hydrocephalus].
Topics: Acetazolamide; Aldosterone; Humans; Hydrocephalus; Infant; Ouabain; Spironolactone; Vasopressins | 1976 |
Nephrotic syndrome associated with bacteraemia after shunt operations for hydrocephalus.
Topics: Edema; Escherichia coli; Female; Fluorescent Antibody Technique; Glomerulonephritis; Humans; Hydroce | 1965 |